ABPI hits back at Corbyn criticism of pharma

21 July 2016
abpi-big-1

The Association of the British Pharmaceutical Industry (ABPI) has hit back after the leader of the Labour Party said pharmaceutical companies should not be allowed to become ‘too dominant’ over the National Health Service (NHS).

Jeremy Corbyn was delivering a speech at University College London this morning to launch his leadership campaign against challenger Owen Smith.

In answer to a question about Mr Smith’s former employment as a drug company lobbyist, Mr Corbyn said medical research should be ‘funded through the Medical Research Council (MRC) and not farmed out to big pharmaceutical companies like Pfizer.’

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical